Tvardi Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Sugar Land, TX
SEC filing record 1 source field available
Fiscal year end
31 December
Tvardi Therapeutics, Inc. has filed 801 SEC EDGAR filings since 06 Dec 2005

SEC filing history

Showing 76-100 of 796 matching filings.

Per page
25
Current page
4
4

4 filing

Filing date
17 Apr 2025
Reporting date
15 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Apr 2025
Reporting date
15 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Apr 2025
Reporting date
15 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Apr 2025
Reporting date
15 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Apr 2025
Reporting date
15 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Apr 2025
Reporting date
15 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Apr 2025
Reporting date
15 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Apr 2025
Reporting date
15 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Apr 2025
Reporting date
15 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Apr 2025
Reporting date
15 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
17 Apr 2025
Reporting date
15 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
17 Apr 2025
Reporting date
15 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
17 Apr 2025
Reporting date
15 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
17 Apr 2025
Reporting date
15 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
17 Apr 2025
Reporting date
15 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
17 Apr 2025
Reporting date
15 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
17 Apr 2025
Reporting date
15 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
17 Apr 2025
Reporting date
15 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
17 Apr 2025
Reporting date
15 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
17 Apr 2025
Reporting date
15 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
17 Apr 2025
Reporting date
15 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-87880

SCHEDULE 13D/A filing

Filing date
16 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .